UK experimental use exemptions: part 1—the original
In the first of a four-part series, Sophie Topham of Marks & Clerk explores how experimental use provides life sciences products with essential relief from patent infringement
- Got a patent, now where to validate? 22-03-2021
- Patent filing strategies for pharma startups 16-03-2021
- The importance of Minerva Surgical v Hologic 02-02-2021
- What 2020 means for the life sciences 15-12-2020
- Pricing, patents and the PMPRB in Canada 14-12-2020
Latest big pharma news
Elysium gets ChromaDex, Dartmouth vitamin patents invalidated
23-09-2021
Dietary supplements company Elysium Health has convinced a Delaware court to invalidate two vitamin B3 patents belonging to rival ChromaDex and Dartmouth College.
Australia backs COVID-19 vaccine waiver
09-09-2021
